Stay updated on KarXT for Schizophrenia: Long-term Clinical Trial
Sign up to get notified when there's something new on the KarXT for Schizophrenia: Long-term Clinical Trial page.

Latest updates to the KarXT for Schizophrenia: Long-term Clinical Trial page
- Check4 days agoChange DetectedSchizophrenia-related topics and MedlinePlus Genetics links were removed from the page’s resource sidebar. This does not change the study’s recorded details or results information.SummaryDifference0.1%

- Check11 days agoChange DetectedAdded related topic links for Schizophrenia and MedlinePlus Genetics, and updated the revision tag from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedAdded sponsor attribution 'Karuna Therapeutics, Inc., a Bristol Myers Squibb company'. Removed the shorter sponsor name 'Karuna Therapeutics', the disease term 'Schizophrenia', and the related topic 'MedlinePlus Genetics' from the page.SummaryDifference0.2%

- Check40 days agoChange DetectedRevision label updated to v3.5.0; the previous v3.4.3 label was removed.SummaryDifference0.0%

- Check47 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check68 days agoChange DetectedSchizophrenia and MedlinePlus Genetics were removed from the page's related topics. This reduces explicit tagging for the study's condition and related genetics resources, potentially affecting searchability and topic discovery.SummaryDifference0.1%

Stay in the know with updates to KarXT for Schizophrenia: Long-term Clinical Trial
Enter your email address, and we'll notify you when there's something new on the KarXT for Schizophrenia: Long-term Clinical Trial page.